Clinical Trial Detail

NCT ID NCT03865212
Title Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Mayo Clinic
Indications

ocular melanoma

melanoma

Therapies

VSV-IFNbetaTYRP1

Age Groups: senior adult

No variant requirements are available.